Business Standard

Friday, December 20, 2024 | 11:16 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

ICMR selects 12 institutes for clinical trial of indigenous Covid vaccine

ICMR has developed the indigenous Covid-19 vaccine (BBV152 COVID vaccine) partnered with Bharat Biotech International Limited (BBIL)

covid, coronavirus, vaccine, drug, pharma
Premium

The 12 institutes have been asked by the ICMR to fast track clinical trials of the vaccine as it is being considered as one of the top priority projects which are being monitored at the topmost level of the government.

Press Trust of India Bhubaneshwar
The ICMR has selected 12 institutes, including one from Odisha, for clinical trial of the country's first indigenous Covid-19 vaccine, an official said on Thursday.
Bhubaneswar-based Institute of Medical Sciences and SUM Hospital under the SOA Deemed to be University, has been chosen by the Indian Council for Medical Research (ICMR) for undertaking human clinical trials of India's first coronavirus vaccine, an official of the institute said.
ICMR has developed the indigenous Covid-19 vaccine (BBV152 COVID vaccine) partnered with Bharat Biotech International Limited (BBIL).
The 12 institutes have been asked by the ICMR to fast track clinical trials of the vaccine as it

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in